HOME >> BIOLOGY >> NEWS
NIEHS allocates $74 million to study environmental causes of disease

sures to Psychosocial Stress and to Addictive Substances for Studies of Health and Disease, led by the National Institute on Drug Abuse.

"Any individuals with the skills, knowledge and abilities required to carry out the proposed research, including scientists who work in NIH laboratories, are encouraged to submit an application for participation in the program," said Weis.

NIEHS will host an information meeting and videoconference, October 20, 2006 in Research Triangle Park, North Carolina, to allow potential applicants to obtain information and clarify any questions about the funding opportunities. Detailed information about the meeting, including time, location, and the new grant opportunities, is available at the Exposure Biology Program website: www.gei.nih.gov/exposurebiology/index.asp.


'"/>

Contact: John Peterson
peterso4@niehs.nih.gov
919-541-7860
NIH/National Institute of Environmental Health Sciences
18-Oct-2006


Page: 1 2 3

Related biology news :

1. NIEHS researchers identify enzyme critical in DNA replication
2. Two at Yale named outstanding new environmental scientists by NIEHS
3. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
4. NIEHS researchers link gene variation to coronary heart disease
5. NIEHS Director unveils new strategic plan for environmental health sciences
6. NIEHS awards $37 million to train emergency and hazardous waste workers
7. NIEHS launches website with information for assessing environmental hazards from Hurricane Katrina
8. A role for public and scientists in NIEHS research plan
9. NIEHS to develop new RNAi library to help fight disease
10. US Department of Defense awards $1.6 million for implantable biochip research
11. Nottingham biosciences million pound injection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIEHS allocates million study environmental causes disease

(Date:11/18/2014)... 17, 2014 The Parenteral Drug Association (PDA) today ... will speak and at least seven more will participate in ... Omni Shoreham Hotel in Washington D.C. , ... have significant support from the regulatory agencies in ... in our effort to help advance the use of ...
(Date:11/12/2014)... , Nov. 12, 2014 Crossmatch™, a leading ... its U.are.U ® fingerprint readers have been deployed ... Central Mexico . The bakery chain ... eliminate payroll issues caused by employees clocking in for ... U.are.U fingerprint readers, Montparnasse relied on paper timecards and ...
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
(Date:11/18/2014)... Array Architects is proud of a 30-year ... nation's hospitals and health systems. It is a niche ... careers to the advancement of both the healthcare and ... field, Laura Silvoy has been chosen to share her ... Conference. , Laura will present her Process Simulation ...
(Date:11/18/2014)... MENLO PARK, Calif. , Nov. 18, 2014 ... leading biotechnology company in the emerging field of ... clinical program, AST-OPC1 (oligodendrocyte progenitor cells) for complete ... as one of ten "Top Advanced Therapies Projects ... "We are delighted to receive this significant industry ...
(Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., a ... treatment of chronic hepatitis B virus (HBV) infection, today ... appointed to its Scientific Advisory Board (SAB).  ... SAB," said Christian S. Schade , Chief Executive ... development experience which will be invaluable to Novira as ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today the formation of a ... guidance to the Company as it advances the ... for the treatment of cutaneous T-cell lymphoma (CTCL), ...
Breaking Biology Technology:Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6
Cached News: